UNSPSC 51391741: Tobuterol

This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17B9PXO2SW. European Medicines Agency schedules Tobuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11135MIG. Tobuterol generally arises in the molecular formula C28H31NO5.

UNSPSC 51391741 Tobuterol is a Commodity code that represents pharmaceutical products — specifically rescue inhalers and related respiratory medications — but recent state and local procurement activity under this code shows minimal relevant solicitation. The two opportunities posted against this code in the recent period are for naloxone and drug deactivation systems (Seminole County, Florida) and a market-information request from the Texas Health and Human Services Commission regarding direct-to-manufacturer prescription programs; neither procurement aligns with the tobuterol product category. The code appears to see little active state and local buying or is mislabeled in the available records, limiting visibility into current demand signals or issuing-body concentration.

Without representative opportunities directly aligned to tobuterol procurement, the geographic spread and buyer mix cannot be reliably characterized from the recent contract record. Business development professionals evaluating this code should treat the current activity as insufficient to establish purchase patterns, repeat buyers, or regional concentration and may need to reference prior-year records, state pharmacy or health-department bid histories, or direct outreach to state Medicaid programs and school district health services to assess whether tobuterol procurement activity exists at scale in any particular jurisdiction.